1
Fay Lorraine Kathleen, Johnson Douglas Scott, Lazerwith Scott Edward, Morris Mark Anthony, Wang Lijuan Jane, Meyers Marvin Jay, Kesten Suzanne Ross, Stiff Cory Michael: Biaryl ether urea compounds. Pfizer Products, Fay Lorraine Kathleen, Johnson Douglas Scott, Lazerwith Scott Edward, Morris Mark Anthony, Wang Lijuan Jane, Meyers Marvin Jay, Kesten Suzanne Ross, Stiff Cory Michael, FULLER Grover F Jr, April 24, 2008: WO/2008/047229 (14 worldwide citation)

The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or co ...


2

3
Guo Chuangxing, Augelli Szafran Corinne E, Barta Nancy Sue, Bender Steven Lee, Bigge Christopher Franklin, Caprathe Bradley William, Chatterjee Arindam, Deal Judith, Dong Liming, Fay Lorraine Kathleen, Hou Xinjun, Hudack Raymond Andrew Jr: Heterobicycles fkbp-ligands. Agouron Pharma, June 2, 2004: EP1423119-A1

Diazabicyclo[3.3.1]nonane derivatives that inhibit the peptidyl-prolyl isomerase enzyme activity associated with FK-506 binding proteins (FKBP) are described for treating neurological disorders. Also described are compounds useful for preparing such inhibitors.


4

5

6
Fay Lorraine Kathleen, Johnson Douglas Scott, Lazerwith Scott Edward, Morris Mark Anthony, Wang Lijuan Jane, Meyers Marvin Jay, Kesten Suzanne Ross, Stiff Cory Michael: Biaryl ether urea compounds. Pfizer Prod, July 8, 2009: EP2076508-A2

The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or co ...


7

8

9

10
Fay Lorraine Kathleen, Johnson Douglas Scott, Meyers Marvin Jay, Thorarensen Atli, Wang Lijuan Jane: Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors. Pfizer, Fay Lorraine Kathleen, Johnson Douglas Scott, Meyers Marvin Jay, Thorarensen Atli, Wang Lijuan Jane, RICHARDSON Peter C, October 22, 2009: WO/2009/127944

The present invention relates to compounds of Formula (I) wherein Ar is optionally substituted phenyl or 6-membered heteroaryl moiety, or a benzisoxazole, pyrrolopyridine, or benzotriazole group; or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermedi ...